NutriBand (NTRB) Non-Current Debt (2016 - 2026)
NutriBand (NTRB) posted Non-Current Debt of $29825.0 for Q2 2026, down 16.83% sequentially from $35861.0 in Q1 2026, and down 43.33% YoY from $52632.0 in Q2 2025.
NutriBand (NTRB) Non-Current Debt (2016 - 2026) Analysis & Trends
NutriBand has reported Non-Current Debt for 9 years, with the latest figure at $29825.0 in Q2 2026.
- Quarterly Non-Current Debt fell 43.33% year-over-year to $29825.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $29825.0 (down 43.33% YoY) and the FY2026 annual result came in at $35861.0, down 38.39% from the prior year.
- Non-Current Debt retreated to $29825.0 in Q2 2026 per NTRB's latest filing, from $35861.0 in the prior quarter.
- Over five years, Non-Current Debt peaked at $115749.0 in Q2 2022 and troughed at $29825.0 in Q2 2026.
- A 5-year average of $76178.9 and a median of $77167.5 in 2024 frame the typical range for Non-Current Debt.
- The sharpest annual moves came in 2022 and 2026: Non-Current Debt advanced 7.1% in 2022, then sank 43.33% in 2026.
- Over 5 years, Non-Current Debt stood at $105512.0 in 2022, then slipped by 19.34% to $85101.0 in 2023, then declined by 25.13% to $63717.0 in 2024, then sank by 34.71% to $41603.0 in 2025, then decreased by 28.31% to $29825.0 in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $29825.0, $35861.0, and $41603.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 8.96 Bn |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 | 29,825.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 29,825.00 |
| Jan 31, 2026 | 35,861.00 |
| Oct 31, 2025 | 41,603.00 |
| Jul 31, 2025 | 56,490.00 |
| Apr 30, 2025 | 52,632.00 |
| Jan 31, 2025 | 58,205.00 |
| Oct 31, 2024 | 63,717.00 |
| Jul 31, 2024 | 69,133.00 |
| Apr 30, 2024 | 74,509.00 |
| Jan 31, 2024 | 79,826.00 |
| Oct 31, 2023 | 85,101.00 |
| Jul 31, 2023 | 90,264.00 |
| Apr 30, 2023 | 95,429.00 |
| Jan 31, 2023 | 100,497.00 |
| Oct 31, 2022 | 105,512.00 |
| Jul 31, 2022 | 115,749.00 |
| Apr 30, 2022 | 115,749.00 |
| Jan 31, 2022 | 101,119.00 |
| Oct 31, 2021 | 104,601.00 |
| Jul 31, 2021 | 108,077.00 |